S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
Log in
NYSE:ACB

Aurora Cannabis Stock Forecast, Price & News

$11.17
-0.37 (-3.21 %)
(As of 01/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.83
Now: $11.17
$11.62
50-Day Range
$8.31
MA: $9.99
$12.04
52-Week Range
$3.71
Now: $11.17
$26.40
Volume16.17 million shs
Average Volume31.55 million shs
Market Capitalization$1.58 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.44
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Aurora Cannabis logo

MarketRank

Overall MarketRank

1.29 out of 5 stars

Medical Sector

916th out of 1,926 stocks

Medicinals & Botanicals Industry

6th out of 33 stocks

Analyst Opinion: 2.9Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone1-855-279-4652
Employees2,731

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$207.89 million
Book Value$13.73 per share

Profitability

Net Income$-2,468,190,000.00
Net Margins-1,238.94%

Miscellaneous

Market Cap$1.58 billion
Next Earnings Date2/11/2021 (Estimated)
OptionableOptionable
$11.17
-0.37 (-3.21 %)
(As of 01/21/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ACB News and Ratings via Email

Sign-up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aurora Cannabis (NYSE:ACB) Frequently Asked Questions

How has Aurora Cannabis' stock been impacted by COVID-19 (Coronavirus)?

Aurora Cannabis' stock was trading at $10.3044 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ACB stock has increased by 8.4% and is now trading at $11.17.
View which stocks have been most impacted by COVID-19
.

Is Aurora Cannabis a buy right now?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 4 sell ratings, 12 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Aurora Cannabis stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACB, but not buy additional shares or sell existing shares.
View analyst ratings for Aurora Cannabis
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Aurora Cannabis?

Wall Street analysts have given Aurora Cannabis a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Aurora Cannabis wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Larry J. Merlo's approval rating as Aurora Cannabis' CEO?

6,978 employees have rated Aurora Cannabis CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among Aurora Cannabis' employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is Aurora Cannabis' next earnings date?

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for Aurora Cannabis
.

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc. (NYSE:ACB) posted its quarterly earnings data on Saturday, November, 14th. The company reported ($0.92) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by $0.68. The company had revenue of $50.90 million for the quarter, compared to analyst estimates of $48.07 million. Aurora Cannabis had a negative net margin of 1,238.94% and a negative return on equity of 16.32%.
View Aurora Cannabis' earnings history
.

When did Aurora Cannabis' stock split? How did Aurora Cannabis' stock split work?

Shares of Aurora Cannabis reverse split on the morning of Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 8th 2020. An investor that had 100 shares of Aurora Cannabis stock prior to the reverse split would have 8 shares after the split.

What guidance has Aurora Cannabis issued on next quarter's earnings?

Aurora Cannabis updated its first quarter 2021 IntraDay earnings guidance on Friday, October, 30th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $48.038-48.038 million.

What price target have analysts set for ACB?

17 brokers have issued twelve-month price targets for Aurora Cannabis' shares. Their forecasts range from $3.60 to $24.00. On average, they expect Aurora Cannabis' stock price to reach $12.66 in the next year. This suggests a possible upside of 13.3% from the stock's current price.
View analysts' price targets for Aurora Cannabis
or view Wall Street analyst' top-rated stocks.

Who are some of Aurora Cannabis' key competitors?

What other stocks do shareholders of Aurora Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include (CGC), Cronos Group (CRON), (APHA), NVIDIA (NVDA), (HEXO), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), General Electric (GE) and Micron Technology (MU).

Who are Aurora Cannabis' key executives?

Aurora Cannabis' management team includes the following people:
  • Mr. Michael Singer, Exec. Chairman (Age 56)
  • Mr. Glen Ibbott, Chief Financial Officer
  • Mr. Allan John Cleiren C.P.A., C.A., ICD.D., Chief Operating Officer
  • Ms. Jillian Swainson, Chief Legal Officer & Corp. Sec.
  • Mr. Miguel Martin, CEO & Director (Age 49)
  • Mr. Darryl Vleeming, Exec. VP of Information Services
  • Dr. Jonathan Page Ph.D., Chief Science Officer (Age 52)
  • Ananth Krishnan, VP of Capital Markets & Investor Relations
  • Michelle Lefler, VP of Communications & PR
  • Mr. Carey Squires, Exec. VP, Corp. Devel. & Strategy

What is Aurora Cannabis' stock symbol?

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

Who are Aurora Cannabis' major shareholders?

Aurora Cannabis' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Kovack Advisors Inc. (0.01%), Aurora Private Wealth Inc. (0.01%) and TRUE Private Wealth Advisors (0.00%).

Which institutional investors are buying Aurora Cannabis stock?

ACB stock was bought by a variety of institutional investors in the last quarter, including Kovack Advisors Inc., Aurora Private Wealth Inc., and TRUE Private Wealth Advisors.

How do I buy shares of Aurora Cannabis?

Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aurora Cannabis' stock price today?

One share of ACB stock can currently be purchased for approximately $11.17.

How big of a company is Aurora Cannabis?

Aurora Cannabis has a market capitalization of $1.58 billion and generates $207.89 million in revenue each year. The company earns $-2,468,190,000.00 in net income (profit) each year or ($2.86) on an earnings per share basis. Aurora Cannabis employs 2,731 workers across the globe.

What is Aurora Cannabis' official website?

The official website for Aurora Cannabis is auroramj.com.

How can I contact Aurora Cannabis?

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at 1-855-279-4652 or via email at [email protected]roramj.com.

This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.